Rx IP Update
Rx IP Update provides timely reports and commentary on developments in Canadian intellectual property law that are of particular interest to the pharmaceutical industry, including summaries of new cases before the courts. If you have any comments on the content or presentation of Rx IP Update, or if you would like more information on a specific issue, please do not hesitate to contact Gunars Gaikis or Nancy Pei (editor). Please click here to subscribe to Rx IP Update

February 2012
Rx IP Update - January 2012
 
 
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
 
Having trouble viewing PDFs in Firefox?